Jessica Madera‐McDonough

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

Lenard A. Adler, Julie Adams, Jessica Madera‐McDonough et al. · Journal of Clinical Psychopharmacology · 2022 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

<p>Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies</p>

Sharon B. Wigal, Tim Wigal, Mary Hobart et al. · Neuropsychiatric Disease and Treatment · 2020 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Matthew Harlin, Murat Yildirim, Pedro Such et al. · CNS Drugs · 2023 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Joseph R. Calabrese, Na Jin, B. Johnson et al. · International Journal of Bipolar Disorders · 2018 · 20 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +14

An alternative start regimen with aripiprazole once-monthly in patients with schizophrenia: population pharmacokinetic analysis of a single-day, two-injection start with gluteal and/or deltoid intramuscular injection

Yanlin Wang, Xiaofeng Wang, Matthew Harlin et al. · Current Medical Research and Opinion · 2021 · 17 citations

Pharmacy, Pharmacology, Pharmacotherapy +17